Explore federal awards
Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
Export these results to CSV · 11 matching records
DEVELOPMENT OF MEDICAL COUNTERMEASURES THROUGH PLANNED CLINICAL TRIALS AND OUTBREAK PREPAREDNESSDepartment of Health and Human Services$5.6M obligationsEnds Dec 31, 2032
PROCUREMENT OF THERAPEUTICS FOR EBOLA, SUDAN AND MARBURG VIRUSESDepartment of Health and Human Services$220.6M obligationsEnds Sep 30, 2030
MAPP EAP - IGF::CL::IGF FOR OTHER FUNCTIONSEXPANDED ACCESS PROTOCOL FOR ZMAPPDepartment of Health and Human Services$28.9M obligationsEnds Dec 31, 2027
THIS COST-PLUS-FIXED-FEE CONTRACT WITH MAPP BIOPHARMACEUTICAL, INC. (MAPP OR CONTRACTOR) IS FOR THE DEVELOPMENT OF MAPP?S THERAPEUTIC INTERVENTION MBP091, AS AN IMMUNOTHERAPY FOR…Department of Health and Human Services$110.9M obligationsEnds May 1, 2031
IGF::OT::IGFDepartment of Health and Human Services$56.7M obligationsEnds Dec 31, 2024
IGF::OT::IGFDepartment of Health and Human Services$7.5M obligationsEnds Jun 30, 2022
DEVELOPMENT OF A PAN-BOTULINUM NEUROTOXIN MEDICAL COUNTERMEASUREDepartment of Health and Human Services$16.4M obligationsEnds Jun 30, 2026
PROCUREMENT OF HUMAN DERIVED MONOCLONAL ANTIBODIES AND ANTIGENSDepartment of Defense$20.5K obligationsEnds Apr 24, 2026
ANTIBODY & ANTIGEN SUPPLYDepartment of Defense$110.5K obligationsEnds Dec 4, 2025
HUMAN-DERIVED MONOCLONAL ANTIBODIES AND RECOMBINANT ANTIGENSDepartment of Defense$60.5K obligationsEnds Feb 25, 2026
IGF::OT::IGFDepartment of Health and Human Services$65.8M obligationsEnds Aug 31, 2021